| pubmed-article:19338566 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19338566 | lifeskim:mentions | umls-concept:C0005684 | lld:lifeskim |
| pubmed-article:19338566 | lifeskim:mentions | umls-concept:C0010819 | lld:lifeskim |
| pubmed-article:19338566 | lifeskim:mentions | umls-concept:C0028581 | lld:lifeskim |
| pubmed-article:19338566 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
| pubmed-article:19338566 | lifeskim:mentions | umls-concept:C0332257 | lld:lifeskim |
| pubmed-article:19338566 | lifeskim:mentions | umls-concept:C1516193 | lld:lifeskim |
| pubmed-article:19338566 | lifeskim:mentions | umls-concept:C1510438 | lld:lifeskim |
| pubmed-article:19338566 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:19338566 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:19338566 | pubmed:dateCreated | 2009-5-20 | lld:pubmed |
| pubmed-article:19338566 | pubmed:abstractText | To determine whether the nuclear matrix protein-22 (NMP22) assay can improve the accuracy of discriminating between high-risk patients with and without bladder cancer. | lld:pubmed |
| pubmed-article:19338566 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19338566 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19338566 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19338566 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19338566 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19338566 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19338566 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19338566 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19338566 | pubmed:month | May | lld:pubmed |
| pubmed-article:19338566 | pubmed:issn | 1464-410X | lld:pubmed |
| pubmed-article:19338566 | pubmed:author | pubmed-author:LotanYairY | lld:pubmed |
| pubmed-article:19338566 | pubmed:author | pubmed-author:ShariatShahro... | lld:pubmed |
| pubmed-article:19338566 | pubmed:author | pubmed-author:KarakiewiczPi... | lld:pubmed |
| pubmed-article:19338566 | pubmed:author | pubmed-author:HuttererGeorg... | lld:pubmed |
| pubmed-article:19338566 | pubmed:author | pubmed-author:CapitanioUmbe... | lld:pubmed |
| pubmed-article:19338566 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19338566 | pubmed:volume | 103 | lld:pubmed |
| pubmed-article:19338566 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19338566 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19338566 | pubmed:pagination | 1368-74 | lld:pubmed |
| pubmed-article:19338566 | pubmed:dateRevised | 2010-3-10 | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:meshHeading | pubmed-meshheading:19338566... | lld:pubmed |
| pubmed-article:19338566 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19338566 | pubmed:articleTitle | Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection. | lld:pubmed |
| pubmed-article:19338566 | pubmed:affiliation | Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. | lld:pubmed |
| pubmed-article:19338566 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19338566 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19338566 | pubmed:publicationType | Multicenter Study | lld:pubmed |
